Sari Atula

Helsinki University Hospital — Finland

Medicine · Health Sciences

24h-index3.0kcitations84works6.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Multiple Sclerosis Research Studies(16), Myasthenia Gravis and Thymoma(14), Acute Ischemic Stroke Management(11), Amyloidosis: Diagnosis, Treatment, Outcomes(10), Peripheral Neuropathies and Disorders(7)

Publications81 total

Tracing the origin of Finnish gelsolin amyloidosis using haplotype sharing trees
2026Open Access
The real-world efficacy of Cladribine tablets and treatment persistence in people with highly active relapsing multiple sclerosis in Finland – A follow-up study after four years of observation
Multiple Sclerosis and Related Disorders·2025Open Access
Differences Between Females and Males in the Diagnostic Delay and Clinical Course of Thymectomised Myasthenia Gravis
European Journal of Neurology·2025· 3 citedOpen Access
Mortality and causes of death for people with multiple sclerosis: a Finnish nationwide register study
Journal of Neurology·2025· 6 citedOpen Access
Incidence and prevalence of multiple sclerosis during eras of evolving diagnostic criteria—a nationwide population-based registry study over five decades
Multiple Sclerosis Journal - Experimental Translational and Clinical·2025· 5 citedOpen Access
Intensive care due to myasthenia gravis: Risk factors and prognosis
European Journal of Neurology·2024· 5 citedOpen Access
Economic and societal burden of myasthenia gravis in Denmark, Finland, and Sweden: A population‐based registry study
European Journal of Neurology·2024· 5 citedOpen Access
Epidemiology of myasthenia gravis in Denmark, Finland and Sweden: a population-based observational study
Journal of Neurology Neurosurgery & Psychiatry·2024· 24 citedOpen Access
EPH185 Healthcare Resource Utilization and Cost Burden Assessment of Patients with Myasthenia Gravis in Denmark, Finland, and Sweden
Value in Health·2023Open Access
Frequency and risk factors of rebound after fingolimod discontinuation – A retrospective study
Multiple Sclerosis and Related Disorders·2023· 19 citedOpen Access
A skewed ratio of free light chains is more common in patients with late-onset than early-onset myasthenia gravis
Immunology Letters·2023· 6 citedOpen Access
Incidental demyelination in magnetic resonance imaging and 10‐year risk of multiple sclerosis: A data lake cohort study
European Journal of Neurology·2023· 3 citedOpen Access
Long-term Survival in Multiple Sclerosis is Improving (P5-3.011)
Neurology·2023
Ectopic germinal centers in the thymus accurately predict prognosis of myasthenia gravis after thymectomy
Modern Pathology·2022· 20 citedOpen Access
Finnish multiple sclerosis patients treated with cladribine tablets: a nationwide registry study
Multiple Sclerosis and Related Disorders·2022· 41 citedOpen Access
Hearing problems in patients with hereditary gelsolin amyloidosis
Orphanet Journal of Rare Diseases·2021Open Access
Initial treatment strategy and clinical outcomes in Finnish MS patients: a propensity-matched study
Journal of Neurology·2021· 38 citedOpen Access
Comorbidities worsen the prognosis of generalized myasthenia gravis post-thymectomy
Journal of the Neurological Sciences·2021· 24 citedOpen Access
Cardiac manifestations in Finnish gelsolin amyloidosis patients
Amyloid·2021· 12 citedOpen Access
Medication adherence/persistence among patients with active multiple sclerosis in Finland
Acta Neurologica Scandinavica·2020· 37 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Sini M. Laakso(11), Daniel Strbian(9), Pentti J. Tienari(8), Merja Soilu‐Hänninen(7), Sari Kiuru‐Enari(7), Atte Meretoja(6), Eeva-Kaisa Schmidt(6), Jukka Putaala(5), Turgut Tatlisumak(5), Tiina Sairanen(5), Markku Kaste(5), Reidar Grénman(5), Stina Syrjänen(5), Matias Viitala(5), Ville Artto(4), Sami Curtze(4), Olli Häppölä(4), Satu Mustanoja(4), Katja Piironen(4), Tuuli Mustonen(4)